Industry Research Reports

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

Global Printer Market 2014-2018

RELATED LINK:

Spectacle Lenses - Top 10 Global Markets Package

This market research report package offers a perspective on the actual market situation, trends and future outlook for spectacle lenses in the top 10 global countries. The studies provide essential market information for decision-makers including:

* Overall market value for spectacle lenses in the top 10 global countries

* Overall market volume for spectacle lenses in the top 10 global countries

* Market value and volume for spectacle lenses by product type

* Product prices

* Forecasts and future outlook of the market

* Country overview, macroeconomic indicators and indicators of doing business

These market studies answer to questions such as:

* What is the size of the spectacle lense markets in the top 10 global countries?

* How are the markets divided into different types of products? Which products are growing fast?

* How the markets have been developing? How does the future look like?

* What is the potential for the markets?

* How the indicators of doing business look like? For example, how easily the contracts are being enforced, or what is the inflation rate and how is it developing?

Product types discussed in the studies are:

* Spectacle lenses of glass

* Spectacle lenses of other materials

Countries included in the package:

Brazil, China, France, Germany, India, Italy, Japan, Russia, United Kingdom and United States

To order this report:

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

RELATED VIDEO:

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2014 in Pharmaceuticals

Summary

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for January 2014 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2013. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house deals database and primary and secondary research.

Scope

* Analysis of the market trends for the pharmaceutical industry in the global arena.

* Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

* Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.

* Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.

* Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

* Analysis of partnership and licensing deals based on clinical stage of development of products.

* Summary of the pharmaceutical deals globally in the six months.

* Information on the top deals happened in the pharmaceutical industry.

* Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

* League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

* Enhance your decision making capability in a more rapid and time sensitive manner.

* Find out the major deal performing segments for investments in your industry.

* Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

* Identify companies that are aggressively looking to raise capital in the market

* Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

* Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.

* Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

* Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

* Identify growth segments and opportunities in each region within the industry.

* Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

To order this report:

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600

Thursday, 17 April 2014

Offshore Drilling Industry in Middle East and Africa to 2016

Offshore Drilling Industry in Middle East and Africa to 2016 - Pre-Salt Potential in West Africa and Significant Gas Finds Off the East African Coast Driving Exploration Activity.

Summary

GBI Research, a leading business intelligence provider, has released its latest research, Offshore Drilling Industry in Middle East and Africa to 2016 - Pre-Salt Potential in West Africa and Significant Gas Finds Off the East African Coast Driving Exploration Activity. The study, produced by the companys Energy Research Group, provides an in-depth analysis of the offshore drilling market in the Middle East and Africa region and highlights the various concerns, shifting trends and major players in the region. The report provides forecasts for the offshore drilling industry in the Middle East and Africa region up to 2016. The report also provides segmented forecasts for the offshore drilling market in major countries in the Middle East and Africa region. In-depth analysis of key trends and challenges in the offshore drilling market in the region are also provided. An analysis of the competitive scenario, data on the offshore wells and drilling expenditure in the region are also provided for each market segment. This report has been compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

* Overview and analysis of the offshore drilling industry in the Middle East and Africa

* Analysis of past market trends and forecasts to 2016

* Analysis and forecast for offshore wells drilled and offshore drilling expenditure

* Country-specific data analysis of Nigeria, Angola, Libya, Egypt, Qatar, UAE, Iran, and Saudi Arabia

* Analysis of opportunities and challenges in the emerging markets of the offshore drilling industry of Middle East and Africa

* Analysis of the competitive scenario for the offshore drilling industry in the Middle East and Africa

Reasons to buy

* Develop business strategies with the help of specific insights into the offshore drilling industry in Middle East and Africa.

* Identify opportunities and challenges in the offshore drilling industry in Middle East and Africa

* Increase future revenues and profitability with the help of insights on the future opportunities and critical success factors in the offshore drilling industry in the Middle East and Africa

* Benchmark operations and strategies against major players in the offshore drilling industry in Middle East and Africa

To order this report:

US: +1 800 986 6819

UK: +44 203 514 2363

India: +91 22 4098 7600